Patent details

EP2858671 Title: ANTIBODY FORMULATION

Basic Information

Publication number:
EP2858671
PCT Application Number:
IB2013054777
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP137448189
PCT Publication Number:
WO2013186700
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIBODY FORMULATION
French Title of Invention:
FORMULATION D'ANTICORPS
German Title of Invention:
ANTIKÖRPERFORMULIERUNG
SPC Number:

Dates

Filing date:
11/06/2013
Grant date:
24/07/2019
EP Publication Date:
15/04/2015
PCT Publication Date:
19/12/2013
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
24/07/2019
EP B1 Publication Date:
24/07/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
11/06/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
17/07/2019
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
STARK, Christoph
Address:
Switzerland (CH)

2

Name:
COSENZA, Marta
Address:
Switzerland (CH)

Priority

Priority Number:
201261658472 P
Priority Date:
12/06/2012
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 39/395; A61K 47/26; C07K 16/28; A61K 47/18;

Publication

European Patent Bulletin

1

Issue number:
201930
Publication date:
24/07/2019
Description:
Grant (B1)

2

Issue number:
201933
Publication date:
14/08/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
30/06/2026
Annual Fee Number:
14
Annual Fee Amount:
198 Euro
Expected Payer:
Last Annual Fee Payment Date:
30/05/2025
Last Annual Fee Paid Number:
13
Last Annual Fee Paid Amount:
180 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages